In today´s episode we interview Greg Resch, Senior Lecturer and Head of the laboratory of bacteriophages at the Lausanne University Hospital (CHUV), and PI in the NCCR Microbiomes.

We started the conversation asking about the latest results regarding the detection of single phage lysis using microfluidics.

We also cover in this episode:

- Some of his work with phage-antibiotic combinations against infective endocarditis, targeting staphylococcus aureus.

- The effect of different antibiotics and phages in MSSA or MRSA strains from their studies, we cover how they also studied phage resistance of several bacteria recovered from those treatments...

- Many more details on how glycosylation and its regulation affect phage susceptibility.

Finally we also talk about regulations of phage therapy in Switzerland and Greg gave us an impressive overview of his career and gave some interesting tips and suggestions for people starting in the phage field.

PhageCast 2025 is sponsored by PrecisionPhage:

⁠www.precisionphage.com

⁠⁠www.phagenomics.net⁠

Contact PrecisionPhage on LinkedIn! 

PrecisionPhage is a Finland-based phage biotech, providing services worldwide:

 🔹phage laboratory R&D services such as on-demand phage isolation

 🔹licensing of bacteriophages against WHO priority pathogens

 🔹ready-to-use and custom-made bioinformatics software for phage and host genome analysis. 

Are you new to phage genome assembly and functional analysis, and would you like to be able to get them done using the latest methods but without the burden of coding or manual work? 

PrecisionPhage welcomes you to get familiar with Phagenomics!

Phagenomics is a web-based software providing automated phage genome assembly, annotation & analysis, as well as comparative genomics. The tool bundles phage bioinformatics in a user-friendly online platform, performing the work of a seasoned phage bioinformatician in an automated manner.

Phagenomics is developed in-house by PrecisionPhage. 

Try Phagenomics for free at ⁠www.phagenomics.net⁠ and sign up for a pro subscription trial.